Chronic non-bacterial osteomyelitis and immune checkpoint molecules.

Clin Rheumatol

Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Sihhiye Campus, 06100, Ankara, Turkey.

Published: January 2024

AI Article Synopsis

  • The study investigated the plasma levels and cell surface expression of TIM-3 and PD-1 checkpoint molecules in pediatric patients with chronic non-bacterial osteomyelitis (CNO).
  • Researchers collected plasma samples from CNO patients during diagnosis and treatment and measured TIM-3 and PD-1 levels using specific assay techniques.
  • Results showed lower plasma PD-1 levels in CNO patients compared to healthy controls, but no significant differences in cellular expression of TIM-3 and PD-1, suggesting T cell exhaustion may not be a significant factor in CNO and pointing to a need for further research.

Article Abstract

Objective: We aimed to investigate the plasma levels and cell surface expression of two checkpoint molecules, TIM-3 (T cell immunoglobulin and mucin domain-containing protein 3) and PD-1 (programmed cell death protein 1), in pediatric patients with chronic non-bacterial osteomyelitis (CNO).

Methods: Plasma samples of CNO patients were collected at diagnosis or during biologic agent treatment. Plasma levels of TIM-3 and PD-1 were measured using the sandwich enzyme-linked immunosorbent assay method, and the expression of the two immune checkpoint molecules on the cell surface was analyzed by isolating peripheral blood mononuclear cells by density gradient centrifugation technique.

Results: Twenty-seven patients with CNO (14 boys, 51.9%) and six healthy controls (3 boys, 50%) were enrolled in the study. There were no age differences between CNO patients and healthy controls (median age 14.5 vs. 13.5 years, respectively, p=0.762). Of the CNO patients, 18 were included at the time of diagnosis while 9 were receiving biologic treatment at enrollment. The median plasma PD-1 levels were significantly lower in the CNO group than in the healthy controls (p=0.011). However, no significant difference was found in the cellular expression of PD-1 and TIM-3 on CD3+CD4+ T cells in patients and healthy controls (p=0.083 and p=0.245, respectively). There was also no statistically significant difference in plasma TIM-3 levels of the patient and control groups (p=0.981).

Conclusion: CNO is an autoinflammatory disease, and overall, our results suggest that T cell exhaustion may not be significant in CNO. Further research is needed to find out whether the immune checkpoints are mainly associated with autoimmunity but not autoinflammation. Key Points • The median plasma PD-1 levels were significantly lower in the CNO group than in the healthy controls. • No significant difference was found in the cellular expression of PD-1 and TIM-3 on CD3+CD4+ T cells in patients and healthy controls. • Our results suggest that T cell exhaustion may not be significant in CNO pathogenesis.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10067-023-06761-yDOI Listing

Publication Analysis

Top Keywords

healthy controls
24
checkpoint molecules
12
cno patients
12
patients healthy
12
chronic non-bacterial
8
non-bacterial osteomyelitis
8
immune checkpoint
8
plasma levels
8
cell surface
8
cno
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!